Verde Competitors

Pink Sheets . USA . 
Stock . Verde Bio Holdings
APHD Stock  USD 0.0002  0.0001  100.00%   
Verde Bio Holdings competes with Xtra Energy; as well as few others. The company conducts business under Financial Services sector and is part of Shell Companies industry. Analyzing Verde Bio competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Verde Bio to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Verde Bio Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Verde Bio competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000112.50
Details
Intrinsic
Valuation
LowRealHigh
0.000.000112.50
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Verde Bio. Your research has to be compared to or analyzed against Verde Bio's peers to derive any actionable benefits. When done correctly, Verde Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Verde Bio Holdings.

Verde Bio Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Verde Bio and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Verde and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Verde Bio Holdings does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ITUP
+ 1.0
USCS
PMPG
+ 1.0
USCS
NOHO
+ 1.0
USCS
PMPG
+ 1.0
ITUP
NOHO
+ 1.0
ITUP
NOHO
+ 1.0
PMPG
  
High negative correlations   
XTPT
- 0.48
TMXN
AWON
- 0.32
TMXN
CCAJ
- 0.28
TMXN
XTPT
- 0.26
CLHI
XTPT
- 0.18
AWON
XTPT
- 0.09
NSPT

Risk-Adjusted Indicators

There is a big difference between Verde Pink Sheet performing well and Verde Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verde Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
USCS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
TMXN  9.83  1.09  0.04  1.78  11.20 
(30.64)
 28.57 
(22.22)
 102.22 
CLHI  10.92  0.63  0.01 (1.08) 16.45 
(33.35)
 44.12 
(45.71)
 155.56 
CCAJ  19.80  4.01  0.14  2.29  17.30 
(40.46)
 50.00 
(40.00)
 164.44 
ITUP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
NSPT  14.46  4.84  0.00 (1.14) 0.00 
 0.00 
 100.00 
(50.00)
 150.00 
PMPG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
NOHO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AWON  9.66 (0.46) 0.00  0.43  0.00 
 0.00 
 19.12 
(23.47)
 121.55 
XTPT  5.30  0.84  0.10 (1.74) 5.01 
(8.77)
 13.33 
(8.33)
 35.38 
All Fundamental Data

Verde Bio Competitive Analysis

The better you understand Verde Bio competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Verde Bio's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Verde Bio's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
APHD USCS TMXN CLHI CCAJ ITUP NSPT PMPG NOHO AWON
 100.00 
 0.0002 
Verde
 0.00 
 0.0001 
USCorp
 20.00 
 0 
Trimax
 69.13 
 0.01 
CLST
 8.33 
 0 
Coastal
 0.00 
 0.0001 
Interups
 100.00 
 0.0002 
Newron
 0.00 
 0.0001 
Premier
 0.00 
 0.0001 
Novation
 20.00 
 0 
A1
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Out of control
Out of control
Out of control
Very steady
Out of control
Very steady
Very steady
Out of control
Market Performance
(90 Days Performance)
OK
Very Weak
Modest
Insignificant
OK
Very Weak
Good
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
About Average
Below Average
High
Below Average
Very High
High
Below Average
Below Average
Very High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Hold
Strong Hold
Cautious Hold
Strong Hold
Hold
Cautious Hold
Hold
Hold
Cautious Hold
Current Ratio
0.1
0.08
7.28
0.14
0.11
0.02
0.02
N/A
0.12
0.1
Net Asset
1.63 K
167.2 K
123.1 K
52.36 M
N/A
78 K
66.02 K
N/A
10 K
N/A
Profit Margin
N/A
N/A
0.27
N/A
-0.0301
N/A
-0.13
N/A
N/A
-0.34
EBITDA
(1.27 M)
(712.85 K)
N/A
(11.2 M)
N/A
N/A
N/A
(74.41 K)
(449.88 K)
N/A
Operating Margin
-0.99
N/A
0.27
-49.58
0.84
-47.06
-0.16
N/A
-0.91
-0.32
Current Valuation
286.8 K
7.92 M
9.59 M
598.73 K
24.75 M
4.83 M
31.95 M
649.77 K
746.99 K
1.61 M
Price To Book
N/A
N/A
N/A
N/A
N/A
N/A
N/A
7.03
N/A
N/A
Retained Earnings
(2.43 M)
(29.38 M)
(17.35 M)
(127.06 M)
(1.33 M)
(337 K)
N/A
(5.9 M)
(14.72 M)
(529 K)
Current Asset
28 K
6 K
51 K
5.68 M
237 K
42 K
N/A
N/A
435 K
38 K
Beta
0.15
2.79
1.26
1.04
1.46
2.23
88.5
-2.46
-16.88
-0.0757
Number Of Employees
11
7
12
3
1
1
5
12
28
4
Shares Outstanding
254.04 K
456.07 M
418.11 M
23.95 M
2.28 B
6.9 M
4.99 B
367.95 M
7.47 B
412.23 M
Cash Flow From Operations
(177.75 K)
(313.18 K)
(369.2 K)
(3.8 M)
N/A
(404.3 K)
(9.81 K)
(51.56 K)
(344.91 K)
(50 K)
Total Debt
1.07 M
3.21 M
188.56 K
N/A
N/A
N/A
541 K
580.58 K
290.75 K
359.67 K
Return On Equity
N/A
N/A
0.52
-3.18
N/A
N/A
N/A
N/A
N/A
N/A
Z Score
N/A
N/A
N/A
-2.8
N/A
-9.2
1.2
N/A
N/A
-25.8
Return On Asset
-0.16
-0.13
0.28
-0.15
N/A
N/A
-0.0097
N/A
-0.22
-1.41
Book Value Per Share
-5.54
-0.001
N/A
-0.051
N/A
75.13
N/A
-0.002
N/A
-0.01
Current Liabilities
986 K
3.15 M
79 K
40.79 M
1.65 M
331 K
N/A
1.1 M
3.55 M
394 K
Total Asset
1.63 K
167.2 K
123.1 K
52.36 M
N/A
78 K
66.02 K
N/A
10 K
42 K
Debt To Equity
N/A
N/A
N/A
N/A
N/A
0.001
N/A
N/A
N/A
N/A
Market Capitalization
412.81 K
4.61 M
9.41 M
565.47 K
2.74 M
4.14 M
1.5 M
73.59 K
14.94 K
618.34 K
Price To Earning
-0.2
N/A
5.9
-0.01
N/A
-14.53
N/A
N/A
-0.05
-4.25
Price To Sales
0.94
412751.0
26.5
4.07
69.37
82.8
586.89
N/A
1.33
5.87
Net Income
(1.58 M)
(54.17 K)
(369.2 K)
(5.19 M)
(28.81 K)
(1.14 M)
(552)
(101.81 K)
(215.75 K)
(262.51 K)
Earnings Per Share
-1.26
N/A
N/A
-0.28
N/A
-0.34
N/A
N/A
-0.002
-0.003
Shares Owned By Insiders
N/A
N/A
N/A
N/A
N/A
39.74
N/A
N/A
7.9
1.82
Revenue
456.04 K
N/A
65.73 K
366 K
N/A
50 K
4.25 K
N/A
N/A
N/A
Working Capital
(958 K)
(3.14 M)
(28 K)
(35.11 M)
(1.41 M)
(289 K)
N/A
(1.1 M)
(3.11 M)
(356 K)
Cash And Equivalents
126.02 K
438.03 K
3.52 K
2.43 M
2.46 K
1.36 M
1.43 K
4.4 K
100.46 K
24.03 K
Cash Per Share
0.5
N/A
N/A
0.1
N/A
0.2
N/A
N/A
N/A
N/A
Gross Profit
11.54 K
(744.83 K)
226.98 K
366 K
N/A
50 K
3.06 K
N/A
198.81 K
181.33 K
Day Typical Price
2.0E-4
1.0E-4
0.0012
0.0071
0.0011
1.0E-4
2.0E-4
1.0E-4
1.0E-4
0.0024
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
527750.0
N/A
N/A
329114.0
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
9.2 T
0.0
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
0.0
1.0
0.0
0.0
0.4444
Period Momentum Indicator
1.0E-4
N/A
2.0E-4
(0.02)
(0.0001)
N/A
1.0E-4
N/A
N/A
4.0E-4
Rate Of Daily Change
2.0
1.0
1.2
0.31
0.92
1.0
2.0
1.0
1.0
1.2
Day Median Price
2.0E-4
1.0E-4
0.0012
0.0071
0.0011
1.0E-4
1.0E-4
1.0E-4
1.0E-4
0.0025
Price Action Indicator
1.0E-4
N/A
1.0E-4
(0.01)
(0.00005)
N/A
1.0E-4
N/A
N/A
1.0E-4
Coefficient Of Variation
812.4
N/A
1561.5
4667.64
736.8
N/A
660.77
N/A
N/A
(2,957)
Mean Deviation
2.98
N/A
9.83
10.92
19.8
N/A
14.46
N/A
N/A
9.66
Jensen Alpha
1.58
N/A
1.09
0.6272
4.01
N/A
4.84
N/A
N/A
(0.46)
Total Risk Alpha
0.221
N/A
(0.73)
(2.32)
0.9509
N/A
1.4
N/A
N/A
(2.23)
Sortino Ratio
N/A
N/A
0.0446
0.0139
0.1445
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
570.24
1355.6
792.78
N/A
N/A
N/A
N/A
N/A
Standard Deviation
12.31
N/A
17.95
27.84
30.61
N/A
30.03
N/A
N/A
16.08
Kurtosis
66.0
N/A
6.2
16.06
5.02
N/A
6.2
N/A
N/A
5.86
Potential Upside
N/A
N/A
28.57
44.12
50.0
N/A
100.0
N/A
N/A
19.12
Treynor Ratio
(1.51)
N/A
1.78
(1.08)
2.29
N/A
(1.14)
N/A
N/A
0.4287
Maximum Drawdown
N/A
N/A
102.22
155.56
164.44
N/A
150.0
N/A
N/A
121.55
Variance
151.52
N/A
322.25
775.01
936.69
N/A
902.1
N/A
N/A
258.58
Market Risk Adjusted Performance
(1.50)
N/A
1.79
(1.07)
2.3
N/A
(1.13)
N/A
N/A
0.4387
Risk Adjusted Performance
0.0983
N/A
0.0558
0.0252
0.1078
N/A
0.119
N/A
N/A
(0.01)
Skewness
8.12
N/A
1.33
2.64
1.67
N/A
2.16
N/A
N/A
(0.47)
Semi Deviation
N/A
N/A
11.2
16.45
17.3
N/A
N/A
N/A
N/A
N/A
Information Ratio
0.1162
N/A
0.0593
0.0184
0.1329
N/A
0.1485
N/A
N/A
(0.04)
Value At Risk
N/A
N/A
(22.22)
(45.71)
(40.00)
N/A
(50.00)
N/A
N/A
(23.47)
Expected Short fall
N/A
N/A
(30.64)
(33.35)
(40.46)
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
23.88
36.82
28.16
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
125.55
270.52
299.38
N/A
N/A
N/A
N/A
N/A

Verde Bio Competition Performance Charts

Five steps to successful analysis of Verde Bio Competition

Verde Bio's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Verde Bio Holdings in relation to its competition. Verde Bio's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Verde Bio in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Verde Bio's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Verde Bio Holdings, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Verde Bio position

In addition to having Verde Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Verde Pink Sheet

Verde Bio financial ratios help investors to determine whether Verde Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verde with respect to the benefits of owning Verde Bio security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY